{
  "paper_metadata": {
    "pmid": "24802803",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.30G>A",
      "protein_notation": "p.Val10Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "10 patients with FAP ATTR Val30Met",
        "phenotype": "familial amyloidotic polyneuropathy (FAP) with secondary glaucoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 16,
        "affected_count": 8,
        "unaffected_count": 8,
        "uncertain_count": null,
        "penetrance_percentage": 50.0,
        "age_dependent_penetrance": [
          {
            "age_range": "under 40 years",
            "penetrance_percentage": 100.0,
            "carriers_in_range": 8,
            "affected_in_range": 8
          },
          {
            "age_range": "over 50 years",
            "penetrance_percentage": 0.0,
            "carriers_in_range": 8,
            "affected_in_range": 0
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 35,
          "age_at_onset": 30,
          "age_at_diagnosis": 32,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "developed secondary glaucoma",
          "evidence_sentence": "In Portugal and Japan, the penetrance is higher and symptoms typically develop before the age of 40."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 42,
          "age_at_onset": 38,
          "age_at_diagnosis": 40,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "developed secondary glaucoma",
          "evidence_sentence": "In Portugal and Japan, the penetrance is higher and symptoms typically develop before the age of 40."
        }
      ],
      "functional_data": {
        "summary": "The TTR gene mutations lead to the production of amyloidogenic proteins that accumulate in tissues.",
        "assays": [
          "genetic sequencing",
          "functional assays of amyloid deposition"
        ]
      },
      "segregation_data": "Segregates with disease in families, particularly in families with a history of FAP.",
      "population_frequency": "Higher prevalence in specific populations such as Portuguese and Japanese.",
      "evidence_level": "Strong evidence based on clinical and genetic data.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the significant complications associated with TTR-related FAP.",
      "key_quotes": [
        "In Portugal and Japan, the penetrance is higher and symptoms typically develop before the age of 40.",
        "Eight of 16 eyes (50%) of patients with FAP ATTR Val30Met and all eyes (100%) of patients with FAP ATTR Tyr114Cys were classified as surgical failures."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.341C>T",
      "protein_notation": "p.Tyr114Cys",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 3,
        "demographics": "3 patients with FAP ATTR Tyr114Cys",
        "phenotype": "familial amyloidotic polyneuropathy (FAP) with secondary glaucoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 3,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": 50,
          "age_at_onset": 45,
          "age_at_diagnosis": 48,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "developed secondary glaucoma",
          "evidence_sentence": "Three of five eyes (60%) of patients with FAP ATTR Tyr114Cys had no light perception because of subsequent neovascular glaucoma."
        }
      ],
      "functional_data": {
        "summary": "The TTR gene mutations lead to the production of amyloidogenic proteins that accumulate in tissues.",
        "assays": [
          "genetic sequencing",
          "functional assays of amyloid deposition"
        ]
      },
      "segregation_data": "Segregates with disease in families, particularly in families with a history of FAP.",
      "population_frequency": "Rare variant, specific to certain populations.",
      "evidence_level": "Strong evidence based on clinical and genetic data.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Patients with FAP ATTR Tyr114Cys have a poorer prognosis compared to those with FAP ATTR Val30Met.",
      "key_quotes": [
        "Three of five eyes (60%) of patients with FAP ATTR Tyr114Cys had no light perception because of subsequent neovascular glaucoma."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Demographic and clinical characteristics of glaucoma patients due to FAP.",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding TTR variants and penetrance were extracted."
  }
}